Yes, anger and aggression are recognized concerns with Lexapro (escitalopram), particularly during treatment initiation or dose changes.
Behavioral activation/agitation—which includes aggression, irritability, and disinhibited behavior—is a documented adverse effect of SSRIs including escitalopram, occurring more commonly in younger children than adolescents and in anxiety disorders compared to depressive disorders 1. The FDA drug label specifically lists anger as an adverse reaction occurring in 2% of pediatric patients with generalized anxiety disorder treated with Lexapro versus 0% with placebo 2.
Key Clinical Patterns
When anger/aggression typically emerges:
- Early in treatment (first month), particularly within the first few weeks 1
- Following dose increases 1
- When combined with drugs that inhibit SSRI metabolism 1
Risk stratification:
- Higher risk: younger children, patients with anxiety disorders 1
- Lower risk: adolescents, patients with depressive disorders 1
Management Algorithm
If anger/aggression develops:
Distinguish from mania/hypomania: Behavioral activation typically occurs early (first month) and improves quickly after dose reduction or discontinuation, whereas mania appears later and persists despite medication changes 1
Immediate intervention: Reduce the escitalopram dose or discontinue if severe 1
Prevention strategy: Start with subtherapeutic "test" doses and use slow up-titration, particularly in younger children 1
Critical Monitoring Requirements
Close monitoring is essential, especially:
- First few weeks of treatment 1
- After any dosage adjustments 1
- In younger children (higher risk population) 1
Patient/family education must occur before treatment initiation about this potential side effect 1.
Important Context
While escitalopram can paradoxically cause anger/aggression as a side effect, recent research demonstrates it effectively reduces irritability and anger in conditions where these are primary symptoms (e.g., premenstrual dysphoric disorder) 3, 4. This highlights that the medication's effect depends on the underlying condition and timing of administration.
The boxed FDA warning for suicidal thinking/behavior through age 24 encompasses behavioral changes including "acting aggressive, being angry or violent" as warning signs requiring immediate medical attention 2.